Acute-care hospitals reduced Clostridium difficile infections by 12%, central line-associated bloodstream infections by 9% and catheter-associated urinary tract infections by 8% in 2018, according to the latest progress report on reducing health care-associated infections from the Centers for Disease Control and Prevention. For more on progress to reduce healthcare-associated infections, visit https://arpsp.cdc.gov/profile/infections.

The AHA’s Health Research & Educational Trust affiliate has worked with CDC to reduce CLABSI, CAUTI, C difficile and methicillin-resistant staphylococcus aureus infections in targeted acute-care hospitals. HRET also has worked with the Agency for Healthcare Research and Quality’s Comprehensive Unit Based Safety Program to prevent CLABSI and CAUTI infections, and with the Centers for Medicare & Medicaid Services’ Hospital Improvement Innovation Networks to reduce hospital-acquired conditions.

Related News Articles

Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The flu hospitalization rate during the 2024-25 flu season was the highest since 2010-11, according to a report published Sept. 12 by the Centers for Disease…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares insights into the organization’s bold approach to improving safety outcomes. From piloting…
Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…